Bjarne Løberg Thorbjørnsen

Bjarne Løberg Thorbjørnsen

Auto-generated profile, based on publicly available information

Bjarne Løberg Thorbjørnsen

Department of Ophthalmology, Oslo University Hospital, Norway Address: Mailbox 4956 Nydalen, 0424 Oslo, Norway

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
HBHilde Bjerkreim
Hilde Bjerkreim
BTBjarne Løberg Thorbjørnsen
Bjarne Løberg Thorbjørnsen
TNTerje Nærland
Terje Nærland
LDLiv Drolsum
Liv Drolsum
OKOlav Kristianslund
Olav Kristianslund
Purpose: To examine whether there was an association between keratoconus and autism spectrum disorder (ASD) in Norway and compare with the general population. Setting: The total population of Norway, including all individuals with ASD and keratoconus. Design: Cross-sectional epidemiological study. Methods: Data were obtained from the Norwegian Patient Registry, which provides information from all publicly funded specialist care. The keratoconus prevalence among persons with ASD was estimated from the total number of individuals with keratoconus in the period 2010-2019 and compared with the prevalence in the general population of Norway during the same period. Results: A population-based sample in Norway identified 23 763 persons with ASD, equivalent to 0.5% of the population, and of these, 115 (0.5%) had a diagnosis of keratoconus. The average age at keratoconus diagnosis among individuals with ASD was 27.3 years, and 83.5% of those diagnosed with both ASD and keratoconus were men. During the same period, the prevalence of keratoconus in the general population of Norway was 0.2%, resulting in an odds ratio of 2.5 (95% CI 2.0-3.0). Conclusions: Based on our findings, people with ASD have significantly higher prevalence of keratoconus compared with the general population of Norway. This implicates that one should have increased awareness for keratoconus and low threshold for corneal tomography in patients with ASD.

20 June 2025 in Cornea
Verified
Journal Article
Closed access
BTBjarne Løberg Thorbjørnsen
Bjarne Løberg Thorbjørnsen
MVMarthe Andrea Velle-Skretteberg
Marthe Andrea Velle-Skretteberg
ATAndreas Thorsrud
Andreas Thorsrud
MSMarit Sæthre
Marit Sæthre
AØAtle Østern
Atle Østern
OKOlav Kristianslund
Olav Kristianslund
Purpose: To evaluate the risk of infectious keratitis after corneal cross-linking (CXL) in eyes with corneal ectasia. Methods: In this retrospective case series, we reviewed the medical records of patients with a diagnosis code for keratitis over a 6-month period after all CXLs performed in the Department of Ophthalmology at Oslo University Hospital from 2007 to 2020. To compare our results with existing literature, we reviewed studies evaluating the risk of keratitis after CXL. Results: A total of 1809 CXLs were performed in our department during the study period. The annual number of CXLs increased from 3 in 2007 to 219 in 2020. We identified 11 (0.6%) cases registered with a keratitis code within 6 months after CXL, of which the physician considered 5 (0.3%, 95% confidence interval, 0.1%–0.6%) to be procedure-related infectious keratitis. The microbiological agents were Staphylococcus aureus (n = 3), Acanthamoeba (n = 1), or unknown (n = 1). To our knowledge, this is the largest European study to report the risk of infectious keratitis after CXL. The literature review, including papers published up to October 2024, identified 23 relevant studies that reported infectious keratitis in 0% to 2.6% of eyes after CXL treatment. Conclusions: We found a low incidence of infectious keratitis after CXL. Our rate was comparable to that reported in the literature, indicating a low risk of this complication in eyes with corneal ectasia treated with CXL.